Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 12—December 2020
Research Letter

Pediatric Lyme Disease Biobank, United States, 2015–2020

Lise E. NigrovicComments to Author , Desire N. Neville, Fran Balamuth, Michael N. Levas, Jonathan E. Bennett, Anupam B. Kharbanda, Amy D. Thompson, John A. Branda, Aris C. Garro, and the Pedi Lyme Net Working Group
Author affiliations: Boston Children's Hospital, Boston, Massachussetts, USA (L.E. Nigrovic); Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA (D.N. Neville); Milwaukee Children's Hospital, Milwaukee, Wisonsin, USA (F. Balamuth); Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA (M.N. Levas); Nemours/Alfred I. duPont Children's Hospital, Wilmington, Delaware, USA (J.E. Bennett, A.D. Thompson); Children’s Minnesota, Minneapolis, Minnesota, USA (A.B. Kharbanda); Massachusetts General Hospital, Boston (J.A. Branda); Rhode Island Hospital, Providence, Rhode Island, USA (A.C. Garro)

Main Article


Characteristics of enrolled children with Lyme disease and clinical mimics, United States, 2015–2020*

Lyme disease
Clinical mimics
p value

Median age, y (IQR) 8 (6–11) 9 (5–14) 0.02
M 345 (67.0) 1,048 (52.9) <0.01
F 170 (33.0) 934 (47.1)
White 438 (85.0) 1,482 (74.8) <0.01
Black 42 (8.2) 255 (12.9)
Asian 8 (1.6) 53 (2.7)
Pacific Islander 0 3 (0.1)
Native American 0 2 (0.1)
Other 22 (4.3) 156 (7.9)
Missing data 5 (1.0) 31 (1.6)
Hispanic 33 (6.4) 234 (11.8) <0.01
Non-Hispanic 480 (93.2) 1,734 (87.5)
Missing data 2 (0.4) 14 (0.7)

*Values are no. (%) except as indicated. NA, not applicable.

Main Article

Page created: September 10, 2020
Page updated: November 19, 2020
Page reviewed: November 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.